Global Micro Bioreactor Market - 2023-2030

Market Overview

Global Micro Bioreactor Market reached US$ 3.5 billion in 2022 and is expected to reach US$ 7.2 billion by 2030 growing with a CAGR of 9.8% during the forecast period 2023-2030. The advancements in biotechnology and biopharmaceutical research, growing focus on process optimization and quality control, and rising demand for high-throughput screening are somee of the factors expected to drive the market over the forecast period.

A microbioreactor is a small-scale bioreactor machine used to cultivate and look at microorganisms, cells, or tissue in a controlled laboratory putting. It's an atomic interpretation of the traditional bioreactor that permits researchers to conduct trials on a smaller scale and with less volume. Micro bioreactors are employed in lots of fields, such as pharmaceutical research, biotechnology, bioengineering, and educational research. They are utilized in cell culture, stem cell studies, drug development, and operation optimization, amongst different things.

Market Dynamics

Increasing Acquisitions of Micro Bioreactor Companies is Expected to Drive Market Growth

On December 6, 2022, Germany's Merck acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. The company is based in the American state of Massachusetts. The acquisition, which closed on December 1, strengthens the Darmstadt-based pharmaceuticals, chemicals, and life science group's upstream portfolio in therapeutic proteins by enabling scalable cell-based perfusion bioreactor processes from 2 ml to 2,000 L with rapid lab-scale process development.

Additionally, on November 17, 2020, Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler, Germany. m2p-labs is best known for its transformative BioLector plate-based micro bioreactors, which support automated solutions for screening and bioprocess development. Thus, from the above factors, the market is expected to drive over the forecast period.

Increasing Product Launches by the Market Players are Expected to Drive Market Growth

On July 19, 2021, CYTENA Bioprocess Solutions, a CELLINK company launched the S.NEST, a state-of-the-art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed its new microbioreactor to disrupt the field of cell line development (CLD).

Micro bioreactors have been instrumental in many research breakthroughs in CLD for a variety of downstream applications, but with the addition of real-time monitoring, the S.NEST is at the forefront of those advances. It also includes patented technology for reciprocating mixing, incubation chambers with individual environmental controls, a camera module for real-time pH and dissolved oxygen monitoring, powerful analytical software to crunch data, compatibility with 96-well or 24-well culture plates, and four chambers for high-throughput culturing of up to 384 wells at once.

CLD researchers looking to streamline upscaling and expansion workflows that previously took weeks to complete will undoubtedly embrace the S.NEST's unique suspension culturing nourished by a continuous supply of oxygen. The S.NEST, as part of CYTENA's extensive portfolio of single-cell instruments, will make highly efficient cell culturing results available to laboratories all over the world. Thus, owing to the above factors, the market is expected to drive over the forecast period.

Lack of Standardized Protocols for Micro bioreactors is Expected to Hamper the Market Growth

Micro bioreactors frequently employ novel technologies and designs, and there are no standard operating procedures for them. This can lead to inconsistencies in data interpretation and make it difficult to share results between systems or laboratories. Standardized protocols and best practices must be developed for micro bioreactors to be widely abandoned and accepted. Thus, from the above factors, the market is expected to hamper market growth over the forecast period.

Russia-Ukraine Conflict Analysis

The ongoing conflict between Russia and Ukraine has the potential to impact the micro bioreactor market. The conflict could hinder cross-border scientific collaborations. The defection of new technologies, including micro bioreactors, is frequently driven by cooperative exploration efforts. However, if these collaborations disintegrate or are put on hold due to the conflict, it may slow down the relinquishment and application of micro bioreactors in the affected regions.

Priorities for exploration may shift during times of conflict to address immediate challenges and philanthropic needs. Funding and coffers that would have been allocated to scientific research, including biotechnology and medicine, could be diverted to dealing with the aftermath of the conflict. This shift in exploration priorities may have an immediate impact on demand for micro bioreactors and overall demand growth.

COVID-19 Impact Analysis:

COVID-19 has positively impacted the global micro bioreactor market. The urgent global need for COVID-19 vaccines has resulted in significant investment in research and development. Micro bioreactors have played a critical role in the rapid development and production of vaccines, allowing for effective process optimization and high-output vaccine campaigners.

This increased demand for vaccine development has positively influenced the demand for micro bioreactors. The outbreak highlighted the importance of quick and scalable bioprocessing technologies. Micro bioreactors have been recognized as valuable tools in biopharmaceutical assiduity due to their small-scale and automated capabilities. The demand for micro bioreactors and related technologies has increased as a result of the need for rapid process development and manufacturing inflexibility.

Segment Analysis

The global micro bioreactor market is segmented based on type, application, and region.

Biopharmaceutical Industry from the Application Segment Account for 32.3% of the Market Share Owing to the Increasing Demand for Biopharmaceutical Products, Flexibility and Scalability, and Technological Advancements in the MicroBioreactors

Micro bioreactors are well-suited for operations in biopharmaceutical exploration, process development, and optimization due to their unique characteristics and advantages. Micro bioreactors allow for the rapid webbing of various cell lines, culture media, and process parameters to optimize bioprocesses. They enable experimenters to estimate multiple experimental conditions at the same time, which speeds up the development of effective and robust bioproduction processes.

Micro bioreactors provide a controlled environment for genetically negotiating cell lines, such as the expression of therapeutic proteins or antibodies. They enable effective evaluation of various gene constructs, selection of high-producing duplicates, and optimization of recombinant protein expression culture conditions.

Micro bioreactors provide a controlled environment for genetically engineering cell lines, including the expression of therapeutic proteins or antibodies. They allow for efficient evaluation of different gene constructs, selection of high-producing clones, and optimization of culture conditions for recombinant protein expression.

For instance, ambr15 is a microscale automated bioreactor system that replicates traditional laboratory-scale bioreactors. The benchtop system is made up of disposable microbioreactor vessels, an automated workstation, and simple software. ambr 15 allows for the automated parallel processing and control of 24 or 48 bioreactor experiments with a single operator. Designed for aseptic operation in a standard laminar airflow biological safety cabinet. When compared to traditional laboratory bioreactors, ambr 15 provides more efficient, consistent, and scalable bioreactor experiments.

Thus, from the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America Accounted for Approximately 39.6% of the Market Share Owing to the Pharmaceutical Companies Wide Presence and a Significant Rise in Micro Bioreactors' Utilization to Produce Novel Ingredients and Drugs for Specific/Uncured Diseases, Strong Investment in Biotechnology and Life Sciences

The North American region's focus on personalized medicine drives the demand for customized cell-based therapies, tissue engineering constructs, and regenerative medicine products. Micro bioreactors play a vital role in the development and production of these personalized therapies by providing a controlled environment for cell culture and process optimization. As the demand for personalized medicine continues to grow, the utilization of micro bioreactors is expected to increase.

The supportive regulatory environment in North America, particularly in the United States, enables faster and more efficient drug development and manufacturing processes. Regulatory agencies like the FDA have shown a willingness to adopt new technologies, including micro bioreactors, which offer benefits in process development, optimization, and cost-effective manufacturing. This favorable regulatory environment reduces barriers to market entry for biopharmaceutical companies utilizing micro bioreactors, thereby driving their adoption.

Competitive Landscape

The major global players in the market include: Sartorius, Stedim, Pall Corporation, M2p-labs, Merck, Applikon Biotechnology, Chemtrix, CerCell, RUAG Space Nyon, PreSens Precision Sensing, and Eppendorf among others.

Why Purchase the Report?

• To visualize the global micro bioreactor market segmentation based on type, application, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global micro bioreactor market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global micro bioreactor market report would provide approximately 53 tables, 50 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies